Partners

download (3)

Forge Biologics

Innovation Partner

Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea into reality. Forge has a 175,000 ft2 facility in Columbus, Ohio, “The Hearth,” to serve as its headquarters. The Hearth is the home of a custom-designed cGMP facility dedicated to AAV viral vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most.

www.forgebiologics.com

Newcells_Full_Logo_Colour_RGB_NO STRAP

Newcells Biotech

Innovation Partner

Newcells Biotech are a fast-growing team of global scientific and industry experts based in the Helix Science Campus of Newcastle-upon-Tyne in the UK. We provide in vitro models to most accurately predict in vivo outcomes, building confidence in the decision making process. Using our expertise in iPSCs, cellular physiology and organoid technology, we have built functional pre-clinical in vitro models of the retina in the form of fully developed retinal organoids and RPE cells.

www.newcellsbiotech.co.uk

Experimentica_Logo

Experimentica

Innovation Partner

Experimentica is a global CRO developing and offering novel preclinical ocular models and services to sponsors from Pharma, Biotech, and Academia.

We offer an industry-leading portfolio of in vivo, in vitro, and ex vivo PoC models in rodents and larger animals, as well as custom models, PK/PD, and Toxicity ocular studies.

Our laboratory sites are located in Finland, Lithuania, and the United States. This enables our team of interdisciplinary scientists to understand and support local and international companies fully.

www.experimentica.com

Biomere logo

Biomere

Event Partner

Our U.S. bi-coastal locations offer an extensive portfolio of preclinical research services from in vitro analyses, early discovery and proof-of-concept to discovery toxicology. Nonclinical capabilities include: pharmacokinetics, lead compound screening, proof of concept, efficacy assessment, pharmacology, mechanism of action, and early lead optimization. Biomere also provides supportive colony maintenance, backup colony support and on site room use agreements.

www.biomere.com

Screenshot 2022-05-24 105309

Ocugen

Industry Partner

At Ocugen, we are developing novel solutions to medical challenges, approaching healthcare innovation with purpose and agility to deliver new breakthroughs for people living with disease.

www.ocugen.com